Suchergebnisse - "Daniyal, Lubna"

PubPharm (8)

1

Epilepsy in neurofibromatosis type 1 : Prevalence, phenotype, and genotype in adults

enthalten in: Epilepsy research | 2024

von Hébert, J. | De Santis, R. | Daniyal, L. | +7

2

Systematic Comparison of Muscle Ultrasound Thickness in Polyneuropathies and Other Neuromuscular Diseases

enthalten in: Neurology and therapy | 2023

von Alnajjar, S. | Fathihelabad, D. | Abraham, A. | +3

3

Systematic Comparison of Muscle Ultrasound Thickness in Polyneuropathies and Other Neuromuscular Diseases

enthalten in: Neurology and Therapy | 2023

von Alnajjar, S. | Fathihelabad, D. | Abraham, A. | +3

4

Systematic Comparison of Muscle Ultrasound Thickness in Polyneuropathies and Other Neuromuscular Diseases

enthalten in: Neurology and Therapy | 2023

von Alnajjar, S. | Fathihelabad, D. | Abraham, A. | +3

5

Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG) : a randomised, double-blind, placebo-controlled, adaptive phase 3 study

enthalten in: The Lancet. Neurology | 2023

von Bril, V. | Drużdż, A. | Grosskreutz, J. | +113

CommentIn: Lancet Neurol. 2023 May;22(5):368-369. - PMID 37059497

6

Retrospective study on the safety of COVID-19 vaccination in myasthenia gravis

enthalten in: Muscle & nerve | 2022

von Urra Pincheira, A. | Alnajjar, S. | Katzberg, H. | +4

CommentIn: Muscle Nerve. 2023 Jan;67(1):1-2. - PMID 36321578

7

Retrospective study on the safety of COVID‐19 vaccination in myasthenia gravis

enthalten in: Muscle & Nerve | 2022

von Urra Pincheira, A. | Alnajjar, S. | Katzberg, H. | +4

8

Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT) : a multicentre, randomised, placebo-controlled, phase 3 trial

enthalten in: The Lancet. Neurology | 2021

von Howard, J. | Bril, V. | Vu, T. | +114

CommentIn: Lancet Neurol. 2021 Jul;20(7):499-500. - PMID 34146498

1
[1]